ERBB2 and neoplasm: To cope with the adverse impact of HER2 heterogeneity on HER2 evaluation, we are the first to propose that dual block HER2 assessment (conducting HER2 assessment on two tumor-containing blocks) in resected specimens of GC is a practical way to increase HER2 positive rate [11, 12].